Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HVIVO PLC Director's Dealing 2013

Feb 28, 2013

7697_dirs_2013-02-28_8882af6d-1b87-4fed-9182-c712e87488bc.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9166Y

Venn Life Sciences Holdings PLC

28 February 2013

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Director's Dealing

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that David Evans, Non Executive Chairman of the Company, has transferred 12,368 ordinary shares from his own name into his pension fund. The shares were transferred at a price of 31.5p

There has been no change in David Evans' beneficial shareholding in Venn as a result of these transactions.

Enquiries:
Venn Life Sciences Holdings Plc
Tony Richardson, Chief Executive Officer Tel: +353 154 99 341
Paul Foulger, Finance Director Tel: 020 7245 1100
Zeus Capital (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones (Corporate Finance) Tel: 0161 831 1512
John Goold (Institutional Sales) Tel: 020 7016 8925
Walbrook PR Ltd Tel: 020 7933 8787 or

Mob: 07980 541 893
Paul McManus [email protected]

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLFSFFRITFIV